Peter J. Blankestijn

18.3k total citations · 3 hit papers
257 papers, 8.5k citations indexed

About

Peter J. Blankestijn is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Emergency Medical Services. According to data from OpenAlex, Peter J. Blankestijn has authored 257 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Nephrology, 98 papers in Cardiology and Cardiovascular Medicine and 63 papers in Emergency Medical Services. Recurrent topics in Peter J. Blankestijn's work include Dialysis and Renal Disease Management (116 papers), Blood Pressure and Hypertension Studies (73 papers) and Central Venous Catheters and Hemodialysis (63 papers). Peter J. Blankestijn is often cited by papers focused on Dialysis and Renal Disease Management (116 papers), Blood Pressure and Hypertension Studies (73 papers) and Central Venous Catheters and Hemodialysis (63 papers). Peter J. Blankestijn collaborates with scholars based in Netherlands, Germany and United States. Peter J. Blankestijn's co-authors include Hein A. Koomans, Michiel L. Bots, Gerry Ligtenberg, Muriël P.C. Grooteman, Menso J. Nubé, Marinus A. van den Dorpel, P. Liam Oey, Piet M. ter Wee, E. Lars Penne and Neelke C. van der Weerd and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Peter J. Blankestijn

251 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes

2012 337 citations Muriël P.C. Grooteman, Marinus A. van den Dorpel et al. Journal of the American Society of Nephrology profile →
Classification of Uremic Toxins and Their Role in Kidney Failure

2021 145 citations Mitchell H. Rosner, Thiago Reis et al. Clinical Journal of the American Society of Nephrology profile →
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure

2023 118 citations Peter J. Blankestijn, Robin W.M. Vernooij et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter J. Blankestijn Netherlands	50	4.0k	2.9k	2.0k	1.9k	1.6k	257	8.5k
Steven M. Brunelli United States	43	4.3k 1.1×	1.6k 0.5×	1.7k 0.8×	993 0.5×	1.4k 0.9×	135	7.5k
Christopher W. McIntyre United Kingdom	46	5.3k 1.3×	2.2k 0.7×	2.1k 1.0×	1.1k 0.6×	1.1k 0.7×	214	8.1k
Bruce F. Culleton Canada	38	7.3k 1.8×	3.4k 1.2×	2.1k 1.1×	849 0.4×	1.8k 1.1×	92	11.9k
Jeroen P. Kooman Netherlands	51	6.0k 1.5×	1.9k 0.7×	2.7k 1.3×	1.9k 1.0×	1.6k 1.0×	276	9.5k
Adrian Covic Romania	55	5.3k 1.3×	1.8k 0.6×	2.1k 1.1×	585 0.3×	1.3k 0.8×	314	9.4k
Anthony J. Bleyer United States	44	4.4k 1.1×	1.7k 0.6×	1.2k 0.6×	481 0.2×	1.7k 1.1×	149	8.0k
Elani Streja United States	49	4.3k 1.1×	910 0.3×	1.6k 0.8×	626 0.3×	1.2k 0.7×	258	7.8k
John T. Daugirdas United States	54	8.8k 2.2×	1.1k 0.4×	3.0k 1.5×	3.6k 1.9×	1.2k 0.8×	229	10.9k
Manjula Kurella Tamura United States	47	5.7k 1.4×	1.7k 0.6×	834 0.4×	507 0.3×	1.0k 0.7×	168	9.5k
Maarten W. Taal United Kingdom	45	3.4k 0.8×	1.5k 0.5×	947 0.5×	428 0.2×	907 0.6×	203	6.6k

Countries citing papers authored by Peter J. Blankestijn

Since Specialization

Citations

This map shows the geographic impact of Peter J. Blankestijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Blankestijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Blankestijn more than expected).

Fields of papers citing papers by Peter J. Blankestijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Blankestijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Blankestijn. The network helps show where Peter J. Blankestijn may publish in the future.

Co-authorship network of co-authors of Peter J. Blankestijn

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Blankestijn. A scholar is included among the top collaborators of Peter J. Blankestijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Blankestijn. Peter J. Blankestijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blankestijn, Peter J.. (2025). Do Medium Cut-Off Dialyzers Offer Any Clinical Benefit or Should We Focus on Hemodiafiltration?. Journal of the American Society of Nephrology. 36(8). 1473–1475. 1 indexed citations

Cromm, Krister, Gregor Liegl, Andrew Davenport, et al.. (2024). Psychosocial Determinants for Self-Reported Health Status in Patients on Hemodialysis. Kidney360. 6(1). 76–85.

Liegl, Gregor, Felix Fischer, Bernard Canaud, et al.. (2024). Using a measurement type-independent metric to compare patterns of determinants between patient-reported versus performance-based physical function in hemodialysis patients. Quality of Life Research. 33(11). 2987–3001. 1 indexed citations

Liegl, Gregor, Felix Fischer, Mark Woodward, et al.. (2023). Physical performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis. Journal of Clinical Epidemiology. 159. 128–138. 3 indexed citations

Bots, Michiel L., Joep van der Leeuw, Johanna AAG Damen, et al.. (2023). One Heartbeat Away from a Prediction Model for Cardiovascular Diseases in Patients with Chronic Kidney Disease: A Systematic Review. Cardiorenal Medicine. 13(1). 109–142. 1 indexed citations

Kashani, Kianoush, Mario Cozzolino, Ziad A. Massy, et al.. (2022). Proposal for a New Classification of Solutes of Interest in Uremia and Hemodialysis. Blood Purification. 52(3). 233–241. 6 indexed citations

Zuijdewijn, Camiel L.M. de Roij van, Menso J. Nubé, Peter J. Blankestijn, et al.. (2022). Long-term peridialytic blood pressure changes are related to mortality. Nephrology Dialysis Transplantation. 38(9). 1992–2001.

Mahfoud, Felix, Michael A. Weber, Roland E. Schmieder, et al.. (2021). Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. American Heart Journal. 239. 90–99. 19 indexed citations

Rosner, Mitchell H., Thiago Reis, Faeq Husain‐Syed, et al.. (2021). Classification of Uremic Toxins and Their Role in Kidney Failure. Clinical Journal of the American Society of Nephrology. 16(12). 1918–1928. 145 indexed citations breakdown →

10.

Canaud, Bernard, Peter J. Blankestijn, Muriël P.C. Grooteman, & Andrew Davenport. (2021). Why and how high volume hemodiafiltration may reduce cardiovascular mortality in stage 5 chronic kidney disease dialysis patients? A comprehensive literature review on mechanisms involved. Seminars in Dialysis. 35(2). 117–128. 26 indexed citations

11.

Barna, Stefi, et al.. (2020). Education for the Anthropocene: Planetary health, sustainable health care, and the health workforce. Medical Teacher. 42(10). 1091–1096. 36 indexed citations

12.

Nubé, Menso J., Tiny Hoekstra, Michiel L. Bots, et al.. (2018). Left ventricular geometric patterns in end‐stage kidney disease: Determinants and course over time. Hemodialysis International. 22(3). 359–368. 11 indexed citations

13.

Jager, Rosa L. de, et al.. (2017). Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. British Journal of Clinical Pharmacology. 84(1). 18–24. 43 indexed citations

14.

Jager, Rosa L. de, Margreet F. Sanders, Wilko Spiering, et al.. (2017). Salt intake and blood pressure response to percutaneous renal denervation in resistant hypertension. Journal of Clinical Hypertension. 19(11). 1125–1133. 5 indexed citations

15.

Bots, Michiel L., et al.. (2015). Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease. Hypertension. 66(5). 998–1005. 36 indexed citations

16.

Zuijdewijn, Camiel L.M. de Roij van, Muriël P.C. Grooteman, Michiel L. Bots, et al.. (2015). Comparing Tests Assessing Protein-Energy Wasting: Relation With Quality of Life. Journal of Renal Nutrition. 26(2). 111–117. 11 indexed citations

17.

Zuijdewijn, Camiel L.M. de Roij van, Michiel L. Bots, Peter J. Blankestijn, et al.. (2015). Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease. American Journal of Nephrology. 42(2). 126–133. 18 indexed citations

18.

Verloop, Willemien L., Willem R.P. Agema, Peter J. Blankestijn, et al.. (2014). Renal denervation for the treatment of hypertension: the Dutch consensus.. PubMed. 72(9). 449–54. 5 indexed citations

19.

Neumann, Jutta, Gerry Ligtenberg, Inge H. H. T. Klein, & Peter J. Blankestijn. (2002). Pathogenesis and treatment of hypertension in polycystic kidney disease. Current Opinion in Nephrology & Hypertension. 11(5). 517–521. 7 indexed citations

20.

Blankestijn, Peter J., et al.. (1999). Haemodialysis access: the case for prospective monitoring. Current Opinion in Nephrology & Hypertension. 8(6). 685–690. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact